The field of cellular immunotherapy has undergone a profound transformation in recent years, with autologous chimeric antigen receptor (CAR) T-cell therapies emerging as the standard-of-care option ...

Over the past decade, several novel immunotherapies have transformed the treatment landscape of relapsed or refractory B-cell acute lymphoblastic leukaemia. In the pivotal TOWER trial, blinatumomab—a ...

RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...

Govt needs to strengthen the health sector to confront the malady …it should also step up effort like it’s already doing in terms of awareness, says Enabulele Nigeria is currently experiencing a Lassa ...

The first Portable Biocontainment Unit has been in the works for years by the U.S. Department of Health and Human Services.